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In many research articles, where protein purification is required for various assays, (protein-protein interactions,
activity assays, etc.), we always have access to the final results, but seldom have access to the raw data required for
an accurate evaluation of the protein quality. This data is extremely important on one hand to critically evaluate the
quality of the proteins used in the described research and, on the other hand, to allow other laboratories to safely
use the described procedure in a reproducible manner. We herby propose to include a standardized methodology
that can easily be incorporated in research papers. Moreover, this methodology can be utilized as a “quality control”
ladder, where the more information given, will lead to a higher ranking of the article. This “quality control” stamp
will allow researchers retrieving relevant and useful materials and methods in the field of protein research.
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At least 50% of the published studies –even in the most
prestigious journals- cannot be reproduced [1-8]. De-
signing, writing, reviewing, publishing, and referring to
data obtained under misleading experimental conditions
is clearly an expensive and unproductive procedure for
all the actors involved in the scientific system. Moreover,
the accumulated errors are amplified by each secondary
publication that was based on non-reproducible data.
Minimal Information (MI) checklists have been pro-
posed for standardization of experimental description
but a general drawback of these platforms is that they
have been primarily conceived for simplifying the bio-
informatics (re)use of experimental data. This effort is
meaningful because metadata analysis of standardized
datasets represents a valuable source of information and
maximizes the usage of already existing results [9-11].
Nevertheless, annotation following mandatory guidelines
is often cumbersome and conflicting MI checklists have
been proposed, despite the simplification efforts made* Correspondence: ario.demarco@ung.si
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article, unless otherwise stated.by the community [12-14]. Moreover, only a few cases of
MI checklists focus on methodologies for recombinant
protein production and quality evaluation [15].
Protein production at lab scale is a straight-forward
procedure. Nevertheless, each step implies making
choices, providing controls, and dealing with the evident
as well as the unappreciated pitfalls of the technology,
such as changes in protein expression, physical and
chemical alterations in protein structure, aggregation,
and proteolysis. Since protein production is very often
not the aim of most research projects, but simply the
way to obtain intermediate reagents to start a research
project, poor protein quality will undermine the robust-
ness of complex multidisciplinary efforts. At the same
time, general (cell) biologists are less aware of protein
quality than specialists such as crystallographers, enzymol-
ogists, or protein chemists and biotechnologists. There-
fore, we wish to propose a methodology for improving the
qualitative evaluation of their proteins to researchers who
are not “protein production specialists”.
Based on many years of experience in the protein pro-
duction field, we would like to propose a practice that
should simplify the assessment of the experimental set
based on a flowchart for initial evaluation of experi-
mental steps in protein production together with thetral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Table 1 The most basic requirements for evaluating
protein quality
In-deep protein biophysical characterization needs specific expertise and
specialized equipment, but any biology lab should be able to assess the
produced proteins using to at least two complementary techniques:
1. PAGE-SDS provides multiple information regarding the quality of the
protein such as the presence of degradation products as well as the
absence of protein contamination.
2. Analytical size exclusion chromatography (SEC) [18] provides
information regarding the correct oligomeric structure of the protein
and the absence of soluble aggregates that can cause non-specific
results in downstream experiments.
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cording to the guidelines of established initiatives such
as Biosharing/MIBBI Foundry.
The protein production flowchart (Additional file 1)
should help following the design of the protein production
protocol outlining the critical points and to standardize
and reproduce the results in other laboratories [16,17].
We suggest editors and reviewers to encourage (not com-
pel) researches to fill as many as possible of the listed re-
quests (following the already available standards) to
acquire the necessary information for the reliable evalu-
ation of the proposed work. Clearly, the set of relevant
data will change according to the final use of the protein
and, therefore, there is no reason for mandatory universal
guidelines (Table 1).
Some editors might even consider attaching a special
section of comments to the electronic version of the paper,
allowing peers to grade the quality of the described protein
production procedure, similar to sites such as TripAdvisor
and others.Additional file
Additional file 1: Flowchart corresponding to a basic lab-scale
protein production protocol. Process evaluation check-list allows for
the precise identification of the steps and illustrates for each module the
meaningful actions necessary to characterize the proteins used as reagents in
biological experiments. Click the links on the image to obtain specifications
and instructions. When available, module annotations should be completed
according to the guidelines of accepted MI platforms: Biosharing/MIBBI Foundry
http://www.biosharing.org/standards/mibbi. For instance: protein _purification_
chromatography; http://wwwdev.ebi.ac.uk/micheckout/checkout/html?output-
type=view_as_html_table&accessions=Gel_electrophoresis.Competing interests
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